Sunday, March 31, 2013

NCBR: "BioBoot Camp held in April"

Quoting from the March 29th posting:

"The Colorado BioScience Association says it will hold a two-day "BioBoot Camp" April 18 and 19 for startups to learn how to build their companies and commercialize life science technologies while avoiding "dangerous pitfalls" along the way.

Jonathan Thorne, CEO of Edgeport Surgical in Boulder, will speak about starting a life science company. Michael Weiner, a partner in business law firm Dorsey, will speak about starting a business."

Link to the posting

Registration Now Open: GoldLab 4th Annual Symposium 2013, “The Biological and Social Evolution of Healthcare: Rube Goldberg and Time”

Registration is now open at the CBSA website for the fourth annual Gold Lab Symposium that will take place on the University of Colorado Boulder campus on Friday and Saturday, May 17 - 18, 2013. This year’s Symposium, entitled “The Biological and Social Evolution of Healthcare: Rube Goldberg and Time,” brings together 17 renowned scientists and healthcare experts to discuss progress and issues in personalized medicine. 

The Gold Lab Symposia were initiated in 2010 to bring together a community of world-class scientists, policy experts, and thinkers to foster deep discussions about biological innovations and the improvement of health care, with a goal of reaching actionable conclusions. Each year, this community identifies the biological technologies that are being integrated into the mainstream to transform key aspects of healthcare. This year the sessions will again explore the expanding scientific basis of personalized medicine; explore drug targets and development, and consider the impact of education, aging, chronic conditions, and immunology on the evolution of healthcare. Presentations on healthcare economics and efficiency and reflections on the future also are included, as well as a discussion about how the efforts toward slowing global warming represent a metaphor for the issues one faces when trying to make healthcare better. 

Speakers scheduled for the event include Stephen Ansolabehere, Ed Baetge, Ian Billick, Charles Cantor, Lakshmi Devi, Stanley Feld, Tim Harris, David Juncker, Daniel Klein, Peter S. Kim, Stephen Macknik, Susana Martinez-Conde, Steven Reed, John Swindle, Mat Todd, Christopher Walsh, and Diana Chapman Walsh. 

Wednesday, March 27, 2013

9News Petline9: Becky Ditchfield & Kay Higgins Share Pippy's Story with Viewers

 This morning, Cat Care Society volunteer Kay Higgins took darling Pippy to appear on 9News Petline9 with Becky Ditchfield. More about Pippy:

* Pippy is an indoor cat, 12-years-old and is in Cat Care Society’s Perpet-U-Care program. The CCS clinic will provide up to 250. Per year of medical treatment for her life.

* She loves laps, head rubs, chin scratches and being talked to and petted.

* She is current on shots, micro-chipped, tested negative for FIV & FELk, uses her litter box and prefers a covered box!

* She does not like her feet handled!

* She loves to look out the window and chat to the birds! * She is a very sweet girl and would love to be “your” lap cat.

Link to Pippy's Petfinder profile

Tuesday, March 26, 2013

Seminar this Saturday, March 30 at Cat Care Society: Why Does My Cat Do That?

 Why Does My Cat Do That? Frequently asked questions about common feline behaviors, presented by Dr. Kerry Muhovich. Dr. Muhovich is a veterinarian who has taught veterinary technician classes for several years at Community College of Denver.

Sat., March 30, 2:00 pm,

Cat Care Society Shelter, lower level conference room

$5 (free for platinum members)

Please RSVP via phone (303.239.9680) or e-mail

John Davidson's Denver Animal Examiner blog featured the March 30th seminar in the March 24th edition...quoting:

"WHY DOES MY CAT DO THAT? -The Cat Care Society's monthly seminar series will feature Dr. Kerry Muhovich on Saturday, March 30 answering frequently asked questions about common feline behaviors. She will speak at 2 p.m. in the lower conference room at the Cat Care Society shelter in Lakewood. The cost is $5 (free for society platinum members), RSVP at (303.239.9680) or email"

Link ot the posting

Saturday, March 23, 2013

Purina 'Pets For People' - Pet Adoption Program for Those 55 Plus

 Purina wants to make it easier than ever for you to welcome a new kitty from Cat Care Society into your home. If you're 55 or over, you qualify for a free, Purina-funded cat adoption at Cat Care Society while funds are available.

Present this flyer when you come to Cat Care Society.

Link for more information:

Print out and bring this flyer with you to adopt:

Friday, March 22, 2013

BioBoot Camp 2013 set for April 18-19, deadline to apply is April 3

 Quoting today's posting:

"DENVER – Colorado BioScience Association will present BioBoot Camp 2013, a free workshop for life science startup companies, on April 18-19 in Denver.

Deadline to apply for the camp by email is April 3. Those accepted will be notified by April 10.

Attendees will learn from experienced entrepreneurs about how to build a company designed to commercialize bioscience technologies while avoiding dangerous pitfalls typically encountered along the way."

Link to InnovatioNews

Wednesday, March 20, 2013

Reminder: Tomorrow, Thur Mar 21, is Feasting For Felines Day at all California Pizza Kitchens on the Front Range (Bring The Flyer)

Join us for the next Feasting for Felines event, benefiting Cat Care Society:

Thursday, March 21, 2013
11 a.m. - 9 p.m.
California Pizza Kitchen - All Front Range Locations
must take this flyer with you and present it to the server

Mark your calendars for upcoming events:
Wednesday, April 17: 730 South Bar & Grill (Wash Park area)
Wednesday, May 15: Restaurant Fundraiser: Wystone's World Teas (Belmar)

Thank you Lakewood Pet Examiner Carrie Dow for helping spread the word about this great CPK event on March 13th: Link to read

And, thanks also to John Davidson, Denver Animal Examiner, for doing the same on March 17th -- Link to read

Saturday, March 16, 2013

New Data: 'Denver area bioscience companies are benefiting from renewed interest from investors and partners.'

 New data from Jones Lang LaSalle ranks the Denver area 13th overall in the US Life Science Industry. Quoting:

"Metro wide, nearly 25,000 people are employed in life sciences-related occupations in the Denver area. The largest research facility in Colorado is the Fitzsimons Life Science District, located in Aurora. With swift growth in the industry over the past few years, Fitzsimons has created a central hub for research dedicated to life sciences, healthcare and education...

...The Colorado BioScience Association works to further Metro Denver and Colorado's life sciences community. Aiding this effort are Colorado programs such as grants, sales tax exemptions, and support for start-up companies...

...Northwest Denver (including Boulder) is a growing region for the life sciences industry and has made remarkable progress over the past decade. It is now considered the main bioscience cluster in Colorado, despite the majority of life science companies in this submarket being small in size (5,000 to 15,000 square feet)."

Link to website overview

Download the Denver report

Link to pdf of the full report (Denver area - see pages 46 and 47)

Wednesday, March 13, 2013

NCBR: 'Drive on to repeal medical device excise tax'

 Quoting from the February 6th NCBR article by Steve Lynn:

"Lawmakers introduced Wednesday [Feb 6] a bill aimed at repealing a 2.3 percent excise tax on medical device technology, though Colorado's congressional delegation was mixed in its support of the measure.

U.S. Reps. Erik Paulsen, R-Minn., and Ron Kind, D-Wisc., introduced the measure with a bipartisan group of 175 co-sponsors in the House. U.S. Sens. Orrin Hatch, R-Utah, and Amy Klobuchar, D-Minn., will introduce a similar bill in the Senate...

...Colorado BioScience Association CEO April Giles was in Washington, D.C. on Wednesday [Feb 6] to support efforts to repeal the bill. Companies statewide have cut jobs or halted hiring because of the tax, Giles said.

The tax on companies, regardless of whether they earn a profit, increases companies' effective tax rates from 15 to 40 percent, she said.

'It really takes their corporate tax from, maybe 39 percent, to 55 percent to 80 percent of all revenue,' Giles said. 'That, again, hurts the abilities of companies to grow either through job creation or to funnel that money back into innovative products.'

A bill to repeal the tax passed the House last year, but the Senate did not back it, and President Obama threatened to veto it.

Giles believes this year's bill has more momentum, although some lawmakers have concerns about how to offset a loss in tax revenue, she said."

Link to the full article

  April Giles was quoted from the NCBR article in a post today [Mar 13] at The Dark Daily:

"Furthermore, April Giles, CEO of Colorado Bioscience Association, claimed in an interview with the Northern Colorado Business Report, 'It really takes their [medical device companies] corporate tax from maybe 39% to 55% to 80% of all revenue.' She noted that this increase hurts companies’ ability to grow."

Link to the Dark Daily

Tuesday, March 12, 2013

Next 'Feasting For Felines' Restaurant Fundraiser For Cat Care Society: March 21 at California Pizza Kitchen (All Front Range Locations)

The Votes are In! In the contest to name Cat Care Society's restaurant fundraiser, there were many great name suggestions, but when the votes were tallied, the winner was..... Feasting for Felines. Several people suggested that name or Feast for Felines. Since the two names are so similar, CCS is awarding $25 King Soopers gift cards to the four people who suggested those names.

Join us for our next Feasting for Felines event:

Thursday, March 21, 2013 11 a.m. - 9 p.m.
California Pizza Kitchen
All Front Range Locations
must take this flyer with you

Mark your calendars:

Wednesday, April 17: 730 South Bar & Grill (Wash Park area)
Wednesday, May 15: Restaurant Fundraiser: Wystone's World Teas (Belmar)

Friday, March 08, 2013

DBJ: "'Biosimilars' bill may face tougher time in Colorado Senate"

 Quoting from the March 7th online article by Ed Sealover:

"A measure that requires pharmacists to inform doctors when they substitute generic “biosimilars” for name-brand biological drugs flew through the Colorado House by an overwhelming margin last week. But a key senator said Thursday that it may have a harder time making it through her chamber... 

...April Giles, president/CEO of the Colorado Bioscience Association, noted that pharmacists don’t have to inform doctors of the generic/name-brand switch until after it’s made, because the main point of the notification clause is to protect patients. She acknowledged that supporters are concerned about what will happen to the bill when it hits the Senate.

'I think what’s most important to think about is the physican-patient relationship,' Giles said. 'When patients have any concern about the way that drugs are reacting to their body, they tend to go to their doctors to talk about it ... The only way the doctor can do that is to know what drugs the patient has gotten.'"

Link to the full article

Thursday, March 07, 2013

Denver Post YourHub/Aurora: ' University of Colorado Hospital educates students about cancer'

 Quoting from the article by Joey Kirchmer:

"Dozens of local students recently got a firsthand look at some of the modern-day, cutting-edge technologies being used to wage war on cancer.

In all, about 120 kids from Smoky Hill High School, Overland High School and Denver School for Science and Technology attended 'Learn About Cancer' day last week at the University of Colorado Anschutz Medical Campus.

The event, co-sponsored by University of Colorado Cancer Center and the Colorado BioScience Association, introduced high-achieving students to possible career opportunities in fields such as cancer research and biomedicine, said Erika Matich, media specialist at University of Colorado Anschutz Medical Campus."

Link to read the full article

Colorado BioScience Institute: Medtronic Denver Community Council Messaging on Colorado Public Radio

The CBSA team thanks the Medtronic Denver Community Council for providing a series of underwriting messages on Colorado Public Radio that share the MDCC's sponsorship of the Colorado BioScience Institute.

Be listening for these words from the Colorado Public Radio announcer...

"Support is provided by the Medtronic Denver Community Council, proud sponsors of the Colorado BioScience Institute. Learn more about the Colorado bioscience community at" 

Link to Listen to the Underwriting Announcement

Link to the Colorado Public Radio website

Learn more about the Medtronic Foundation's Community Councils

Learn more about the Colorado BioScience Institute

Video Highlights: CBSA's 2013 BioTech Pharma Symposium

 Colorado BioScience Association held its annual BioTech Pharma Symposium on February 28, 2013, at the Denver Four Seasons Hotel. Many thanks to sponsors of the event: Fitzsimons Redevelopment Authority, GlaxoSmithKline, Johnson and Johnson, Merck, Pfizer and PhRMA. Here are the video highlights:

Introductory Remarks: Genia Long, Analysis Group, Inc., presented 'The Biopharmaceutical Pipeline: Evolving Science, Hope for Patients'

Kevin Koch, Ph.D., President and Chief Scientific Officer, Array BioPharma on Networking: 'I really want to know what my customer wants'

Array BioPharma Overview: Kevin Koch, Ph.D., President and Chief Scientific Officer

GlobeImmune Overview - Timothy Rodell, M.D., CEO and President

Inviragen Overview - Dan Stinchcomb, PhD, Co-founder and CEO

Link to the CBSA YouTube Channel

Link to learn more about the 2013 BioTech Pharma Symposium

Tuesday, March 05, 2013

Petline9: Suellen Scott Takes Blossom to the 9News Backyard Today

 CCS Development Director Suellen Scott took Blossom to 9News Petline9 with Chief Meteorologist Kathy Sabine.

Suellen shares: "Blossom is 7 1/2 years old. She is microchipped, spayed, litter box trained, vaccinated and tested for disease. A dilute calico with short hair, she has lived in a quiet home w/ other cats and dogs. Blossom was adopted at CCS when she was a kitten, but was recently returned because her humans are going to senior housing and can't take all their pets. Blossom has a lot to say and is very vocal. She prefers lap sitting over being held and she will pad and knead on you. She loves her canned food and would prefer that it is cut up, as she is a slow eater!! Blossom is looking for a quiet indoor home where she can share her love with a very special human."

For more information about adopting Blossom call Cat Care Society at (303) 239-9680 or visit the website:

Sunday, March 03, 2013

ColoradoBiz: 'Colorado innovators weigh impact of contested tax: Tough hike for medical device makers"

 Colorado BioScience Association President/CEO April Giles was quoted extensively speaking on behalf of Colorado's Medical Device Industry in Debra Melani's March 1 article. Quoting, in part, to recap Giles' quotes:

"In 2010, faced with paying for President Obama’s $1 trillion Affordable Care Act, lawmakers approved the tax, expected to raise as much as $29 billion in the next 10 years from the $100-billion-plus medical-device industry. The tax made it through the end-of-year fiscal-cliff congressional session intact, but as ColoradoBiz went to press in mid-February, bipartisan bills calling for repeal of the medical-device tax had been introduced in both the U.S. House and the Senate. At stake, according to those in the field, are thousands of jobs and America’s leading edge in the medical-device marketplace. 

'I am absolutely worried,' said April Giles, president and CEO of the Colorado BioScience Association, which has more than 350 members. 'I’m worried for our small businesses, because it really limits their ability to get their product out into the market in a way that they can be successful and reinvest those dollars back into innovation.' The excise tax is levied on total revenue of all medical-device companies, regardless of size or profits. 

Medical-device companies, responsible for everything from MRIs to hip replacements, are significant players in the national and state economy, working to improve patient care. Colorado employs 27,000 people in the bioscience industry, creating 122,000 direct and indirect jobs. That translates into about $10 billion in payroll, at an average annual salary of $82,000, Giles said. The medical-device sector makes up about half of the state’s bioscience industry and has grown by about 14 percent in the past three years, she said...

...Although Giles suspects a less profound impact on the state’s larger companies, they will still feel the blow, she said. 'Our small companies are really driving a lot of innovation right now, and big companies are looking for them to do that for acquisition or partnering. It really does hurt our competitive edge.'... 

...While most in the industry understand they need to contribute to change, Giles said, the question is: At what cost? Colorado companies are already reporting job cuts, investment woes and even troubles with vendors, which are critical to manufacturing-job success, Giles said. 'Vendors are concerned about the ripple effect.” Sure, if a product is significant, a company will get it to market, she said. “But there might be fewer jobs behind it, and it will take longer to get there. Patient access to new technology will be slowed.'... 

...Giles emphasized that her industry knows it should help pay for reform. 'We are from the perspective that everyone is willing to put something on the table to get us there. But we need the Congress to stop playing wars and come to a consensus on what’s going to help this country get back on its feet.'" 
Link to the full article

Friday, March 01, 2013

DBJ: 'Colorado may take shot at distributing vaccines'

Quoting from the March 1st article by Ed Sealover: 

"The state government is looking at becoming a provider — possibly the sole provider — of children’s vaccines in Colorado, which worries bioscience companies and some doctors... 

...Because there are tiered prices for biotech companies to sell to public and private providers of vaccines in the United States — with private-market prices being higher — the state becoming a major purchaser could lower revenue, said Dan Stinchcomb, CEO of vaccine developer Inviragen Inc. of Fort Collins. That would make it harder for startups working on new vaccines to find capital funding and could lead to fewer companies working to develop better vaccines, said April Giles, president/CEO of the Colorado Bioscience Association

  Link to the full article (subscription required for full access)